GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Institutional Ownership

Medicure (TSXV:MPH) Institutional Ownership : 2.44% (As of Jun. 07, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Medicure Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Medicure's institutional ownership is 2.44%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Medicure's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Medicure's Float Percentage Of Total Shares Outstanding is 48.53%.

Medicure Institutional Ownership Historical Data

The historical data trend for Medicure's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure Institutional Ownership Chart

Medicure Historical Data

The historical data trend for Medicure can be seen below:

2020-03-31 2020-04-30 2020-05-31 2020-06-30 2020-07-31 2020-08-31 2020-09-30 2020-10-31 2020-11-30 2020-12-31
Institutional Ownership 10.56 9.98 9.07 8.14 7.51 7.51 7.51 6.54 4.85 2.44

Medicure Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Medicure (TSXV:MPH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Institutional Ownership
Comparable Companies
XCNQ:IMCC TSXV:HASH XCNQ:BAMM TSXV:NDVA XCNQ:XTRX TSX:WLLW TSXV:CANB NEOE:FH TSX:VPH XCNQ:SLNG XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
MCUJF:USA NGQ1:Germany
Address
2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6
Website
https://www.medicure.com
Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.
Executives
Albert David Friesen Director, Senior Officer

Medicure (TSXV:MPH) Headlines

No Headlines